Patrick Kortebein, MD | |
1 Health Plz, East Hanover, NJ 07936-1016 | |
(862) 778-9800 | |
Not Available |
Full Name | Patrick Kortebein |
---|---|
Gender | Male |
Speciality | Physical Medicine & Rehabilitation |
Location | 1 Health Plz, East Hanover, New Jersey |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568552131 | NPI | - | NPPES |
152733001 | Medicaid | AR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | E-3851 (Arkansas) | Primary |
Entity Name | Johns Hopkins University |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
How do you find a cure for a devastating pediatric brain disease so rare that it can take decades to build a meaningful research base? In 2010, the parents of a patient created the Rasmussen Encephalitis (RE) Children's Project to help solve this problem. In a short amount of time, the foundation has raised funds to establish a consortium of top researchers, build a collection of samples of the disease from around the world and support projects to study the disease tissue and search for genetic links. The goal is to find a cure.
ManTech International Corporation today completed the acquisition of Evolvent Technologies, Inc. of Herndon, Va., a focused healthcare-systems integrator with particular strength in federal healthcare systems.
Two proteins have been identified as prime suspects in the proliferation of breast cancer in a study by an international consortium of researchers from Rice University, the University of North Texas, Denton (UNT); the University of California, San Diego (UCSD); and the Hebrew University of Jerusalem.
Investigators at The Cancer Institute of New Jersey have presented new research at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium. Their work highlights how a variation in a person's DNA sequence is associated with an earlier age of onset for breast cancer that is stimulated by the hormone estrogen (estrogen receptor positive).
Cocaine toxicity due to drug overdose results in more than half a million emergency room visits annually. Despite these alarming statistics, there is no Food and Drug Administration-approved pharmacotherapy specifically designed to treat cocaine toxicity. Emergency medical personnel are limited to treating only the immediate life-threatening symptoms of patients, while toxic levels of cocaine and its metabolic break-down products persist and continue to damage the cardiovascular system, liver and brain.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Patrick Kortebein, MD 1 Health Plz, East Hanover, NJ 07936-1016 Ph: (862) 778-9800 | Patrick Kortebein, MD 1 Health Plz, East Hanover, NJ 07936-1016 Ph: (862) 778-9800 |
News Archive
How do you find a cure for a devastating pediatric brain disease so rare that it can take decades to build a meaningful research base? In 2010, the parents of a patient created the Rasmussen Encephalitis (RE) Children's Project to help solve this problem. In a short amount of time, the foundation has raised funds to establish a consortium of top researchers, build a collection of samples of the disease from around the world and support projects to study the disease tissue and search for genetic links. The goal is to find a cure.
ManTech International Corporation today completed the acquisition of Evolvent Technologies, Inc. of Herndon, Va., a focused healthcare-systems integrator with particular strength in federal healthcare systems.
Two proteins have been identified as prime suspects in the proliferation of breast cancer in a study by an international consortium of researchers from Rice University, the University of North Texas, Denton (UNT); the University of California, San Diego (UCSD); and the Hebrew University of Jerusalem.
Investigators at The Cancer Institute of New Jersey have presented new research at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium. Their work highlights how a variation in a person's DNA sequence is associated with an earlier age of onset for breast cancer that is stimulated by the hormone estrogen (estrogen receptor positive).
Cocaine toxicity due to drug overdose results in more than half a million emergency room visits annually. Despite these alarming statistics, there is no Food and Drug Administration-approved pharmacotherapy specifically designed to treat cocaine toxicity. Emergency medical personnel are limited to treating only the immediate life-threatening symptoms of patients, while toxic levels of cocaine and its metabolic break-down products persist and continue to damage the cardiovascular system, liver and brain.
› Verified 9 days ago
Sarah Gaballah, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 120 Eagle Rock Ave, Ste 154, East Hanover, NJ 07936 Phone: 201-447-4772 Fax: 862-701-6444 | |
Amanda Ansley Kelly, Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 120 Eagle Rock Ave Ste 154, East Hanover, NJ 07936 Phone: 120-144-7477 | |
Dr. Cristin Mckenna, M.D., PH.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 120 Eagle Rock Ave Ste 154, East Hanover, NJ 07936 Phone: 201-447-4772 Fax: 973-243-6861 | |
Dr. Jean Bachar, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 120 Eagle Rock Ave Ste 154, East Hanover, NJ 07936 Phone: 201-447-4772 Fax: 862-701-6444 | |
Dr. Julie T Lin, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 120 Eagle Rock Ave, Suite 154, East Hanover, NJ 07936 Phone: 201-447-4772 | |
James D Girardy, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 120 Eagle Rock Ave, Suite 154, East Hanover, NJ 07936 Phone: 201-407-5145 Fax: 862-701-6444 |